Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleLYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.AuthorsGao, Jian-Jun; Gao, Zu-Hua; Zhao, Cui-Rong; Yuan, Yi; Cui, Shu-Xiang; Zhang, Xiao-Fan; Cheng, Yan-Na; Xu, Wen-Fang; Tang, Wei; Qu, Xian-JunPublicationInvestigational New Drugs, 2011, Vol 29, Issue 4, p574ISSN0167-6997Publication typeArticleDOI10.1007/s10637-010-9391-9